Surprisingly, The National Agency of Drug and Food Control (BPOM) gave the gesture to directing the clinical test for Ivermectin to assess its viability and wellbeing for treating COVID-19 patients in Indonesia. Certainly, with the endorsement, the clinical preliminary of Ivermectin as a COVID-19 medication can be directed soon. This is what BPOM head Penny K. Lukito expressed during a …